| Schedule of notes payable |
The following table presents notes payable as of June 30, 2026 and December 31, 2025:
|
|
|
|
|
|
|
|
|
|
|
June 30,
2026 |
|
|
December 31,
2025 |
|
On July 27, 2018, the Company entered into a Bridge Loan Agreement and Promissory Note, with an interest rate of 0.50% per month for the first six months and 0.75% per month through the Maturity Date of July 27, 2019. On April 27, 2026, BioStem Technologies, Inc. entered into a Settlement Agreement and Release to resolve all disputes arising from loan agreements in default. |
|
$ |
- |
|
|
$ |
1,000,000 |
|
On October 5, 2018, the Company entered into a Bridge Loan Agreement and Promissory Note, with an interest rate of 0.50%, per month for the first six months and 0.75% per month through the Maturity Date of October 5, 2019. On April 27, 2026, BioStem Technologies, Inc. entered into a Settlement Agreement and Release to resolve all disputes arising from loan agreements in default. |
|
|
- |
|
|
|
2,000,000 |
|
On April 23, 2026, the Company entered into a Bridge Loan Agreement and Promissory Note, with an interest rate of 0.50% per month for the first six months and 0.75% per month through the Maturity Date of April 23, 2027. |
|
|
1,000,000 |
|
|
|
- |
|
Total notes payable |
|
|
1,000,000 |
|
|
|
3,000,000 |
|
Less: current portion of notes payable |
|
|
(1,000,000 |
) |
|
|
(3,000,000 |
) |
Notes payable-long-term |
|
$ |
- |
|
|
$ |
- |
|
|